Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-02-22
2011-02-22
Blanchard, David J. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388800, C530S391300, C530S391700, C424S130100, C424S141100, C424S142100, C424S155100, C435S069600, C435S070210, C536S023530
Reexamination Certificate
active
07893217
ABSTRACT:
The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to antibodies directed against the polypeptides and to methods for using the polynucleotides, and polypeptides, and antibodies in research, diagnosis, and therapeutic applications.
REFERENCES:
patent: 4831175 (1989-05-01), Gansow et al.
patent: 5246692 (1993-09-01), Gansow et al.
patent: 5804382 (1998-09-01), Sytkowski et al.
patent: 5871969 (1999-02-01), Hastings et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6177244 (2001-01-01), Sytkowski et al.
patent: 6287777 (2001-09-01), Sytkowski et al.
patent: 6682736 (2004-01-01), Hanson et al.
patent: 6682902 (2004-01-01), Harkins et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 7307154 (2007-12-01), Harkins et al.
patent: 2005/0147556 (2005-07-01), Ali et al.
patent: WO 98/45442 (1998-10-01), None
patent: WO 98/50073 (1998-11-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO 00/23108 (2000-04-01), None
patent: WO 01/44291 (2001-06-01), None
Gillespie et al, Chemistry, 2nd edition, 1989, Simon and Schuster, pp. A-12 and A-13.
Umemiya et al., “M-Spondin, a novel ECM protein highly homologous to vertebrate F-spondin, is localized at the muscle attachment sites in theDrosophilaembryo,”Develop. Biol., 1997, 186:165-76 (Exhibit 7).
Manda et al., “Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display,”Genomics, 1999, 61:5-14 (Exhibit 8).
Klar et al., “F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension,”Cell, 1992, 69:95-110 (Exhibit 9).
Feinstein et al., “F-spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons,”Development, 1999, 126:3637-48 (Exhibit 10).
Burstyn-Cohen et al., “Accumulation of F-spondin in injured peripheral nerve promotes the outgrowth of sensory axons,”J. Neuroscience, 1998, 18:8875-85 (Exhibit 11).
Higashijima et al., Mindin/F-Spondin Family: Novel ECM Proteins Expressed in the Zebrafish Embryoic Axis,Developmental Biology, 1997, 192:211-27 (Exhibit 12).
Sodee et al., “Preliminary Imaging Results Using In-11 Labeled CYT-356 (Prostascint™) in the Detection of Recurrent Prostate Cancer,”Clinical Nuclear Medicine, 1996, 21:759-67 (Exhibit 13).
Mikayama et al., “Molecular cloning and functional expression of cDNA encoding glycosylation-inhibiting factor,”PNAS, 1993, 90:10056-60 (Exhibit 14).
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” inThe Protein Folding Problem and Tertiary Structure Prediction, 1994, ed. Birkhauser, Boston, MA, pp. 433 and 492-495 (Exhibit 15).
Saini et al., “Regulation of the turnover of mRNAs encoding cellular oncoproteins,”Biochem. Cell Biol., 1991, 69:415-7 (Exhibit 16).
Hershey, “Protein Phosphorylation Controls Transition Rates,”J. Biol. Chem., 1989, 264:20832-6 (Exhibit 17).
Kreitman, Robert J., “Immunotoxins,”Expert Opinion on Pharmacotherapy, 2000, 1:1117-29 (Exhibit 18).
Colman, P. M., “Effects of amino acid sequence changes on antibody-antigen interactions,”Research in Immunology, 1994, 145:33-6 (Exhibit 19).
Kipriyanov, Sergey M. and Melvyn Little, “Generation of Recombinant Antibodies,”Molecular Biotechnology, 1999, 12:173-201 (Exhibit 20).
Miriam-Webster Online Dictionary, accessed on Jun. 21, 2006 (Exhibit 21).
Chemistry, Second Edition, Ronald J. Gillespie et al., eds., Prentice Hall, Englewood Cliffs, NJ, 1989, pp. A-12-A-13 (Exhibit 22).
Lederman, Seth et al., “A Single Amino Acid Substitution in a Common African Allele of the CD4 Molecule Ablates Binding of the Monoclonal Antibody, OKT4,”Molecular Immunology, 1991, 28:1171-81 (Exhibit 26).
Li, Choh Hao et al., “β-Endorphin omission analogs: Dissociation of immunoreactivity from other biological activities,”Proc. Natl. Acad. Sci. USA, 1980, 77:3211-4 (Exhibit 27).
Reiger, Rigomar et al.,Glossary of Genetics and Cyogenetics, Classical and Molecular, 4thEd. Springer-Verlay, Berlin, 1976, pp. 17-18 (Exhibit 28).
Fundamental Immunology, William E. Paul, ed., New York, NY, 1993, pp. 292-295 (Exhibit 29).
Rudikoff, Stuart et al., “Single amino acid substitution altering antigen-binding specificity,”Proc. Natl. Acad. Sci. USA, 1982, 79:1979-83 (Exhibit 30).
Harkins Richard
Parkes Deborah
Parry Gordon
Parry Renate
Schneider Douglas W.
Bayer Schering Pharma Aktiengesellschaft
Blanchard David J.
Mandel & Adriano
LandOfFree
Isolated human antibodies that bind epitopes on RG1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated human antibodies that bind epitopes on RG1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated human antibodies that bind epitopes on RG1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2646154